MIC B12
US$ 21.96
bpc 157 human clinical trials safety fda warning Banned: Key Facts on the Latest Decision Regeneration or Risk? A Narrative
Description
Suitable for cell-based assays and molecular pathway analysis
Dose-proportional pharmacokinetics were observed following single dose intravenous administration of 2.5 to 10 g of hydroxocobalamin in healthy volunteers
BPC-157 and TB-500 should be clear
doi: 10.1016/0002-9610(91)91120-8
